Singer Taemin is making a comeback with a new album that showcases his evolved artistic vision.Set to drop on Monday at 6:00 p.m. (KST) across all music platforms, Taemin's latest mini-album PHASE 1: Soft Violence is generating buzz in the K-pop worl
Taemin's New Mini-Album Phase 1: Soft Violence Set to Redefine K-Pop Aesthetics
Younghoon's 2026 Fan Meeting Highlights: Exclusive Behind-the-Scenes and Special Performances

Younghoon's 2026 Fan Meeting Highlights: Exclusive Behind-the-Scenes and Special Performances

THE BOYZ's Younghoon held his first solo fan meeting since debut, delighting fans with an intimate gathering.Namoo Actors, Younghoon's agency, reported that the 2026 Younghoon Fan Meeting: 영: Flow To You took place on August 29 at Yonsei University's
Infinite Releases Heartfelt New Single "I Still Remember": A Must-Listen for K-Pop Fans!

Infinite Releases Heartfelt New Single "I Still Remember": A Must-Listen for K-Pop Fans!

The group INFINITE has officially released their new single "I Still Remember."INFINITE dropped their latest digital single "I Still Remember" across major streaming platforms on Monday noon. The track explores the idea that despite the passage of ti
Stray Kids Makes History: First Foreign Male Artist to Perform at Tokyo National Stadium

Stray Kids Makes History: First Foreign Male Artist to Perform at Tokyo National Stadium

Stray Kids has made history as the first international male act to perform at Tokyo's National Stadium.JYP Entertainment, the group's agency, announced on Tuesday that Stray Kids held concerts for their new world tour RUN IT at Tokyo's National Stadi
BLACKPINK's Jisoo Unveils New Single "CLICK": What to Expect from the Teaser Release!

BLACKPINK's Jisoo Unveils New Single "CLICK": What to Expect from the Teaser Release!

BLACKPINK's Jisoo Teases Concept for New Solo Single "CLICK"YG Entertainment, Jisoo's agency, revealed on Tuesday that teasers and cover images for her upcoming single "CLICK" were released on official social media platforms on August 28 and 31.The v
Chungha's New Single "Mexico": What to Expect from Her Captivating Comeback?

Chungha's New Single "Mexico": What to Expect from Her Captivating Comeback?

Singer Chungha is set to make a comeback with an even more intense and alluring presence.The K-pop star will drop her new digital single "México" on various online music platforms at 6:00 p.m. (Korean time) on Tuesday."México" marks Chungha's first r
LE SSERAFIM Unveils New Single "Made My Night": What to Expect from Their Latest Release?

LE SSERAFIM Unveils New Single "Made My Night": What to Expect from Their Latest Release?

LE SSERAFIM's latest single title has been unveiled.On Tuesday, LE SSERAFIM (Kim Chaewon, Sakura, Heo Yunjin, Kazuha, Hong Eunchae) dropped two track samplers for their sophomore single album Made My Night via HYBE Labels' YouTube channel and Source
Revolutionizing Kidney Stone Surgery: How the AI-Powered Zamenix Robot Enhances Patient Safety

Revolutionizing Kidney Stone Surgery: How the AI-Powered Zamenix Robot Enhances Patient Safety

On Tuesday, ROEN Surgical, a surgical robot platform company, announced that it has received approval from South Korea's Ministry of Food and Drug Safety for modifications to its artificial intelligence (AI)-powered kidney stone surgery robot, Zameni
Revolutionary Liver Cancer Treatment: How Rivoceranib + Camrelizumab Outperforms Sorafenib in Young Patients

Revolutionary Liver Cancer Treatment: How Rivoceranib + Camrelizumab Outperforms Sorafenib in Young Patients

A recent study has shown that HLB's combination therapy for liver cancer, using Rivoceranib + Camrelizumab, demonstrates consistent efficacy across all age groups. Notably, the treatment improved progression-free survival (PFS) even among younger liv
Revolutionizing Knee Treatment: How MIUChon iPSC Therapy Could Replace Joint Surgery by 2026

Revolutionizing Knee Treatment: How MIUChon iPSC Therapy Could Replace Joint Surgery by 2026

YiPSCELL, a regenerative medicine company specializing in induced pluripotent stem cells (iPSCs), is making significant strides in its clinical research for the cartilage cell therapy candidate MIUChon. The company aims to complete its main clinical

© Copyright by News1. All Rights Reserved.